Updated 08:05 GMT, 20 Nov 2026 SPX 7,175.83 -2.02% NDX 26,517.05 -2.21% VIX 28.44 +15.80% GOLD 3,574.90 -3.00% CL 82.63 -0.70% BTC 61,735.58 -0.27%
NAS100 26,517 −2.21% S&P 7,176 −2.02% GOLD $3,575 −3.00% BTC $61,736 −0.27% VIX 28.44 +15.80% latest tape · as of 08:05 UTC
The Screen · Consumer Cyclical

Caleres, Inc.

CAL · the NYSE · USD · Market cap $473M

FAIL · Does not pass the screen
12.82 USD

Price as of 19 Nov 2026Daily close, not a live quote

Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price12.82 USD at the 19 Nov 2026 close
  • Fair value24.92. Our model only; no analyst estimate to cross-check.
  • Our value readUndervalued vs our fair value, as of 19 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.48)
  • Last reviewed19 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $22.79 to $27.50, base estimate $24.92 (screen dated 2026-11-19).

Current read
Markup ?
Undervalued · screened 2026-11-19
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.48, read 2026-11-15
  • Ethical does not pass the values gate
Price12.82 USD
Fair value24.92Our model only; no analyst estimate to cross-check.
Ethical score70.0/100
Value readUndervaluedas of 19 Nov 2026
Our investment reviews on this name
2026-11-10Read Markup13.57-5.5% to today Accumulation gives way to Markup first Markup read since August
2026-10-20Read Accumulation13.14-2.4% to today Markdown gives way to Accumulation after a 9% rise in 7 days
2026-10-13Read Markdown12.09+6.0% to today Accumulation gives way to Markdown
2026-10-02Read Accumulation11.91+7.6% to today ✓Markup gives way to Accumulation

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Caleres, Inc. holds its Markup at $12.82. Consolidating, no directional conviction, held for 4 days.

As held on the ledger · 2026-11-19
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 4 days
Price at the screen$12.82
ValuationN/A trailing · 5.52 forward price to earnings
Values screenFAIL · score 70.0
Beta0.72
The Workings

Five Screens: CAL's Results

FAIL. Debt ratio

TestFigureLimitStatus
Business activity Permissible Permissible core business Pass
Debt load 183.67% Below 33% Fail
Interest-bearing cash 6.14% Below 33% Pass
Receivables 0.00% Below 49% Pass

Definitions, sources and threshold rules: ticker values-screen methodology.

The Ethical Read

Why It Falls Short, in Plain English

Caleres,'s business is in a permissible area, but its interest-bearing debt is about 184% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when CAL's ethical verdict changes

Today CAL does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our model only; no analyst estimate to cross-check.

Our analysis reads Undervalued vs our fair value, as of 19 Nov 2026: it trades at roughly a 49% discount to our $24.92 fair value, weak competitive moat, 8.70% revenue growth.

Model construction and limits: fair-value methodology.

22.79Conservative24.92Base case27.50Growth case 12.82Price

Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 48.6% discount to the base estimate.

Price History & Projections

Where our models see it going: fair-value estimate $24.92, with a range of $22.79 to $27.50, dated to the 2026-11-19 screen.

How our estimate and third-party targets differ.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E5.5xcheap for a company growing this fast
EPS, trailing-0.21
EPS, forward2.16
Revenue growth+8.7%steady growth
Profit margin-0.2%currently unprofitable
Return on equity-1.6%not currently earning a positive return on equity
Dividend yield2.13%
Debt to equity1.46a meaningful debt load worth watching
Beta0.72steadier than the market
MoatWEAK
Market cap$473M

CAL-specific watchpoints · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Metric definitions and interpretation rules: ticker-page methodology.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-17 Markup $13.20 -2.7% Entry 12

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-11-10 Markup · changed $13.57 +0.6% Entry 11

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-11-03 Accumulation $13.49 +2.7% Entry 10

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-10-27 Accumulation $13.14 +0.0% Entry 9

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-10-20 Accumulation · changed $13.14 +8.7% Entry 8

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 5% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-10-13 Markdown · changed $12.09 +1.5% Entry 7

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-10-02 Accumulation · changed $11.91 -3.7% Entry 6

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-08-24 Markup $12.37 +0.0% Entry 5

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-07-24 Markup $12.37 +0.0% Entry 4

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

2026-07-18 Markup $12.37 +0.0% Entry 3

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it none, with a mean price target of $17.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The Political Ledger · Congressional Disclosures
Disclosures naming CAL
DatePoliticianPartyTypeAmount
2026-10-27 Gil Cisneros Democrat sell 100K–250K
2026-10-23 Gil Cisneros Democrat buy 250K–500K
2026-10-19 Gil Cisneros Democrat buy 250K–500K
2026-10-09 Ro Khanna Democrat buy 1K–15K
2026-10-08 Ro Khanna Democrat sell 50K–100K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $12.06 +13.0% · $1,130 +13.0%
2 months $12.52 +8.9% · $1,089 +8.9%
3 months $9.35 +45.8% $0.07 $1,465 +46.5%
6 months $13.37 +1.9% $0.14 $1,030 +3.0%
1 year $14.10 -3.3% $0.21 $982 -1.8%
2 years $31.83 -57.2% $0.49 $444 -55.6%
3 years $22.91 -40.5% $0.77 $629 -37.1%
5 years $26.17 -47.9% $1.33 $572 -42.8%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever CAL does next, these words stay.

Caleres, Inc. · CAL · Markup · $12.82
Recorded 2026-11-19 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.